pubmed.ncbi.nlm.nih.gov

Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives - PubMed

  • ️Fri Jan 01 2021

Review

Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives

Max Jonathan Stumpf et al. Biomedicines. 2021.

Abstract

Pseudoxanthoma elasticum (PXE) is a rare, genetic, metabolic disease with an estimated prevalence of between 1 per 25,000 and 56,000. Its main hallmarks are characteristic skin lesions, development of choroidal neovascularization, and early-onset arterial calcification accompanied by a severe reduction in quality-of-life. Underlying the pathology are recessively transmitted pathogenic variants of the ABCC6 gene, which results in a deficiency of ABCC6 protein. This results in reduced levels of peripheral pyrophosphate, a strong inhibitor of peripheral calcification, but also dysregulation of blood lipids. Although various treatment options have emerged during the last 20 years, many are either already outdated or not yet ready to be applied generally. Clinical physicians often are left stranded while patients suffer from the consequences of outdated therapies, or feel unrecognized by their attending doctors who may feel uncertain about using new therapeutic approaches or not even know about them. In this review, we summarize the broad spectrum of treatment options for PXE, focusing on currently available clinical options, the latest research and development, and future perspectives.

Keywords: PXE; atherosclerosis; choroidal neovascularization; gene therapy; pseudoxanthoma elasticum; pyrophosphate; skin; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

  • Pseudoxanthoma elasticum.

    Germain DP. Germain DP. Orphanet J Rare Dis. 2017 May 10;12(1):85. doi: 10.1186/s13023-017-0639-8. Orphanet J Rare Dis. 2017. PMID: 28486967 Free PMC article. Review.

  • Genotype-phenotype correlation in pseudoxanthoma elasticum.

    Bartstra JW, Risseeuw S, de Jong PA, van Os B, Kalsbeek L, Mol C, Baas AF, Verschuere S, Vanakker O, Florijn RJ, Hendrikse J, Mali W, Imhof S, Ossewaarde-van Norel J, van Leeuwen R, Spiering W. Bartstra JW, et al. Atherosclerosis. 2021 May;324:18-26. doi: 10.1016/j.atherosclerosis.2021.03.012. Epub 2021 Mar 13. Atherosclerosis. 2021. PMID: 33812167

  • Early arterial calcification does not correlate with bone loss in pseudoxanthoma elasticum.

    Martin L, Hoppé E, Kauffenstein G, Omarjee L, Navasiolava N, Henni S, Willoteaux S, Leftheriotis G. Martin L, et al. Bone. 2017 Oct;103:88-92. doi: 10.1016/j.bone.2017.06.017. Epub 2017 Jun 27. Bone. 2017. PMID: 28658601

  • ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.

    Shimada BK, Pomozi V, Zoll J, Kuo S, Martin L, Le Saux O. Shimada BK, et al. Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555. Int J Mol Sci. 2021. PMID: 33925341 Free PMC article. Review.

  • Pseudoxanthoma elasticum overlaps hereditary spastic paraplegia type 56.

    Legrand A, Pujol C, Durand CM, Mesnil A, Rubera I, Duranton C, Zuily S, Sousa AB, Renaud M, Boucher JL, Pietrancosta N, Adham S, Orssaud C, Marelli C, Casali C, Ziccardi L, Villain N, Ewenczyk C, Durr A, Mignot C, Stevanin G, Billon C, Hureaux M, Jeunemaitre X, Goizet C, Albuisson J. Legrand A, et al. J Intern Med. 2021 May;289(5):709-725. doi: 10.1111/joim.13193. Epub 2021 Mar 31. J Intern Med. 2021. PMID: 33107650

Cited by

References

    1. Bartstra J.W., Risseeuw S., de Jong P.A., van Os B., Kalsbeek L., Mol C., Baas A.F., Verschuere S., Vanakker O., Florijn R.J., et al. Genotype-phenotype correlation in pseudoxanthoma elasticum. Atherosclerosis. 2021;324:18–26. doi: 10.1016/j.atherosclerosis.2021.03.012. - DOI - PubMed
    1. Kranenburg G., Baas A.F., Jong PA de Asselbergs F.W., Visseren F.L.J., Spiering W. The prevalence of pseudoxanthoma elasticum: Revised estimations based on genotyping in a high vascular risk cohort. Eur. J. Med Genet. 2019;62:90–92. doi: 10.1016/j.ejmg.2018.05.020. - DOI - PubMed
    1. Van Soest S., Swart J., Tijmes N., Sandkuijl L.A., Rommers J., Bergen A.A. A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1. Genome Res. 1997;7:830–834. doi: 10.1101/gr.7.8.830. - DOI - PMC - PubMed
    1. Le Saux O., Urbana Z., Göring H.H., Csiszara K., Popec F.M., Richardsd A., Ronchettie I.P., Terryf S., Bercovitchg L., Lebwohl M.G., et al. Pseudoxanthoma Elasticum Maps to an 820-kb Region of the p13.1 Region of Chromosome 16. Genomic. 1999;62:10585762. doi: 10.1006/geno.1999.5925. - DOI - PubMed
    1. Neldner K.H. Pseudoxanthoma elasticum. Int. J. Dermatol. 1988;27:98–100. doi: 10.1111/j.1365-4362.1988.tb01280.x. - DOI - PubMed

Publication types

LinkOut - more resources